U.S. Markets open in 54 hrs, 38 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,309.92 | -154.48 | -1.48% |
| NASDAQ | 2,138.44 | -37.61 | -1.73% |
| S&P 500 | 1,091.49 | -19.14 | -1.72% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 49.99 09:32 AM EST | |
|---|---|---|
| Day High | 51.43 12:48 PM EST |
|
| Range | 1.44 |
| Volume | 1.25 M | |
|---|---|---|
| 30-Day Avg Vol | 4.03 M |
|
| Difference | -68.93% |
| Market Cap | 13.55 B | |
|---|---|---|
| Mkt Cap Chg | -119.42 M |
| Shares Out | 265.38 M | |
|---|---|---|
| % Shrs Traded | 0.47% | |
| 1yr EPS Est | 3.013 |
| 52-Wk Low | 47.09 | |
|---|---|---|
| 52-Wk High | 73.75 |
|
| Range | 26.66 |
| Prev Close | 51.52 11/25/09 | |
|---|---|---|
| Today's Open | 50.67 | |
| Change | -1.65% |
| Dividend (TTM) | — | |
|---|---|---|
| Div Yield (TTM) | — | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.53 M |
| Revenue (LFY) | 2.20 B | |
|---|---|---|
| Earnings (LFY) | 86.53 M | |
| Earnings (MRQ) | 123.63 M | |
| Next Earn Est | 0.307 | |
| Next Earnings | 02/17/2010 |
|
| EPS (TTM) | 0.57 | |
| 1yr EPS Growth | -0.23% |
| P/E Ratio (TTM) | 29.02 | |
|---|---|---|
| P/E Ratio (Fwd) | 16.00 | |
| PEG Ratio | 0.73 | |
| Return on Equity | 2.49 | |
| Beta | 0.33 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Genzyme makes big money off small-time diseases. The company's product portfolio focuses on rare genetic disorders as well as kidney disease, cancer, and biosurgery. One of its main products, Cerezyme, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.307 2/17/10 | — — |
—
—
|
| Last Quarter | 0.437 9/30/09 | 0.31 9/30/09 |
-0.127
Missed
|
| 2 Quarters Ago | 0.854 6/30/09 | 0.85 6/30/09 |
-0.004
Missed
|
| Quarterly - 06/30/2005 | Annual - 2004 | |
|---|---|---|
| Total Revenue | 668.14 M | 2.20 B |
| Gross Profit | 522.89 M | 1.50 B |
| Operating Income | 164.67 M | 514.00 M |
| Net Income | 123.63 M | 86.53 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts